Wells Fargo & Company »

Outlook Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4k 1.4k 1.00
2025-06-30 $3.2k 1.6k 2.00
2025-03-31 $10k 10k 1.00
2024-12-31 $19k 9.3k 2.00
2024-09-30 $28k 5.6k 5.00
2024-06-30 $21k 2.9k 7.38
2024-03-31 $28k 2.3k 12.00